文献
J-GLOBAL ID:201802259004240795
整理番号:18A0927466
便秘を伴う過敏性腸症候群の日本人患者における使用のためのリナacloの最適用量の決定:第II相無作為化二重盲検プラセボ対照試験【JST・京大機械翻訳】
Determining an optimal dose of linaclotide for use in Japanese patients with irritable bowel syndrome with constipation: A phase II randomized, double-blind, placebo-controlled study
著者 (9件):
Fukudo S.
(Department of Behavioral Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan)
,
Nakajima A.
(Department of Gastroenterology, Yokohama City University, Yokohama, Japan)
,
Fujiyama Y.
(Shiga University of Medical Science, Ohtsu, Japan)
,
Kosako M.
(Japan-Asia Clinical Development 2, Development, Astellas Pharma Inc., Tokyo, Japan)
,
Nakagawa A.
(Japan-Asia Clinical Development 2, Development, Astellas Pharma Inc., Tokyo, Japan)
,
Akiho H.
(Japan-Asia Clinical Development 2, Development, Astellas Pharma Inc., Tokyo, Japan)
,
Nakashima Y.
(Japan-Asia Data Science, Development, Astellas Pharma Inc., Tokyo, Japan)
,
Johnston J. M.
(Ironwood Pharmaceuticals Inc., Cambridge, MA, USA)
,
Miwa H.
(Division of Gastroenterology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan)
資料名:
Neurogastroenterology & Motility
(Neurogastroenterology & Motility)
巻:
30
号:
5
ページ:
e13275
発行年:
2018年
JST資料番号:
W2694A
ISSN:
1350-1925
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)